Genetic background of skin barrier dysfunction in the pathogenesis of psoriasis vulgaris

Postepy Dermatologii i Alergologii

Volumn 32, Issue 2, 2015, Pages 123-126

  Stawczyk Macieja, Marta ^a   Szczerkowska Dobosz, Aneta ^a   Rebała, Krzysztof ^a   Purzycka Bohdan, Dorota ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Epidermal differentiation complex; Late cornified envelope; Psoriasis

Indexed keywords

CATHEPSIN L; CATHEPSIN V; CERAMIDE; CYSTATIN M; ENVELOPE PROTEIN; FILAGGRIN; KERATIN; LEGUMAIN; LIPID; LORICRIN; PROLINE RICH PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN S 100; STEFIN A; STRESS ACTIVATED PROTEIN KINASE; STRUCTURAL PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HEREDITY; HUMAN; IMMUNE RESPONSE; INHERITANCE; KERATINIZATION; KERATINOCYTE; LOSS OF FUNCTION MUTATION; PATHOGENESIS; PERMEABILITY BARRIER; PSORIASIS VULGARIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; SKIN FUNCTION;

EID: 84927762664     PISSN: 1642395X     EISSN: 22990046     Source Type: Journal    
DOI: 10.5114/pdia.2014.44003     Document Type: Article

References (31)

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
2. Capon F, Munro M, Barker J, et al. Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002; 118: 745-51.
3. Nair RP, Stuart PE, Nistor I, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006; 78: 827-51.
4. Shabgah AG, Fattahi E, Shahneh FZ. Interleukin-17 in human inflammatory diseases. Postep Derm Alergol 2014; 31: 256-61.
5. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
6. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31: 5-19.
7. Broome AM, Ryan D, Eckert RL. S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 2003; 51: 675-85.
8. Marshall D, Hardman MJ, Nield KM, Byrne C. Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci USA 2001; 98: 13031-6.
9. Zhao XP, Elder JT. Positional cloning of novel skin-specific genes from the human epidermal differentiation complex. Genomics 1997; 45: 250-8.
10. Jackson B, Tilli CM, Hardman MJ, et al. Late cornified envelope family in differentiating epithelia - response to calcium and ultraviolet irradiation. J Invest Dermatol 2005; 124: 1062-70.
11. Chen H, Toh TKL, Szeverenyi I, et al. Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis. J Invest Dermatol 2009; 129: 606-14.
12. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barier protein filaggrin are a major predisposing factor for atopis dermatitis. Nat Genet 2006; 38: 441-6.
13. Huffmeier U, Traupe H, Oji V, et al. Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patients. J Invest Dermatol 2007; 127: 1367-70.
14. Thyssrn J, Johansen J, Carlsen B, et al. The filaggrin null genotypes R501X and 2282del4 seem not to be associated with psoriasis: results from general population study and meta-analysis. J Eur Acad Dermatol Venereol 2012; 26: 782-4.
15. Kim BE, Howell MD, Guttman-Yassky E, et al. TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J Invest Dermatol 2011; 131: 1272-9.
16. Giardina E, Capon F, De Rosa MC, et al. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet 2004; 68: 639-45.
17. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007; 120: 150-5.
18. Kim BE, Leung DY, Boguniewicz M, et al. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 2008; 126: 332-7.
19. Wolf R, Mascia F, Dharamsi A, et al. Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2010; 2: 61ra90.
20. Mischke D, Korge BP, Marenholz I, et al. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J Invest Dermatol 1996; 106: 989-92.
21. de Cid R, Riveira-Munoz E, Zeeuwen PL, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 2009; 41: 211-5.
22. Huffmeier U, Bergboer JG, Becker T, et al. Replication of LCE3C-LCE3B CNV as a risk factor for psoriasis and analysis of interaction with other genetic risk factors. J Invest Dermatol 2010; 130: 979-84.
23. Li M, Wu Z, Chen G, et al. Deletion of the late cornified envelope genes LCE3C and LCE3B is associated with psoriasis in a Chinese population. J Invest Dermatol 2011; 131: 1639-43.
24. Xu L, Li Y, Zhang X, et al. Deletion of LCE3C and LCE3B genes is associated with psoriasis in a northern Chinese population. Br J Dermatol 2011; 165: 882-7.
25. Riveira-Munoz E, He SM, Escaramis G, et al. Meta-analysis confirms the LCE3C-LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol 2011; 131: 1105-9.
26. Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene luster at 1q21. Nat Genet 2009; 41: 205-10.
27. Strange A, Capon F, Spencer CC, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42: 985-90.
28. Samuelsson L, Stiller C, Friberg C, et al. Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5. J Invest Dermatol 2004; 122: 1399-400.
29. Vasilopoulos Y, Walters K, Cork MJ, et al. Association analysis of the skin barrier gene cystatin A at the PSORS5 locus in psoriatic patients: evidence for interaction between PSORS1 and PSORS5. Eur J Hum Genet 2008; 16: 1002-9.
30. Zeeuwen PL, van Vlijmen-Willems IM, Jansen BJ, et al. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol 2001; 116: 693-701.
31. Cheng T, Tjabringa TS, van Vlijmen-Willems IM, et al. The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis. Br J Dermatol 2009; 161: 252-64.